Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00384462 · ClinicalTrials.gov registry record
Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 346
- Enrollment target
NCT00384462: Completed study, sponsored by MedImmune.
NCT00384462 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 346 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00384462 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 346 participants
- Enrollment target
Study Summary
The purpose of this study is to describe respiratory syncytial virus (RSV) hospitalization rates and to begin to address the utilization of outpatient resources for RSV medically-attended lower respiratory tract infections (MALRI) in 32-35 week gestational age (GA) premature infants who are less than 6 months of age and do not receive treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 346 participants |
| Start Date | 2006-10 |
| Est. Completion | 2008-01 |
What the finished NCT00384462 record still lists
NCT00384462 is an observational study that tracks outcomes without assigning an intervention. The registered 346 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00384462 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00384462 about?
NCT00384462 is a clinical study titled "Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants". The purpose of this study is to describe respiratory syncytial virus (RSV) hospitalization rates and to begin to address the utilization of outpatient resources for RSV medically-attended lower respiratory tract infections (MALRI) in 32-35 week gestational age (GA) premature infants who are less tha...
What is the current status of trial NCT00384462?
This trial is currently completed. The enrollment target is 346 participants. The study started on 2006-10. Estimated completion is 2008-01.
Who is sponsoring clinical trial NCT00384462?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267886 · 346 participants · Phase 4
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
- NCT06705842 · 346 participants · Phase 4
APPI-Cost Trial for Perforated Appendicitis
- NCT06932887 · 346 participants · Phase 3
The Beat Pain Better Trial
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia